Quantcast

Latest Zostavax Stories

2011-03-24 14:57:00

SILVER SPRING, Md., March 24, 2011 /PRNewswire-USNewswire/ -- The Food and Drug Administration (FDA) today approved the use of Zostavax, a live attenuated virus vaccine, for the prevention of shingles in individuals 50 to 59 years of age. Zostavax is already approved for use in individuals 60 years of age and older. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) In the United States shingles affects approximately 200,000 healthy people between the ages of 50 and 59, per year....

2011-01-12 14:08:20

Vaccination for herpes zoster, a painful rash commonly known as shingles, among a large group of older adults was associated with a reduced risk of this condition, regardless of age, race or the presence of chronic diseases, according to a study in the January 12 issue of JAMA. "The pain of herpes zoster is often disabling and can last for months or even years, a complication termed postherpetic neuralgia. Approximately 1 million episodes of herpes zoster occur in the United States annually,...

2008-08-05 12:01:07

Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead http://www.reportlinker.com/p091765/Commercial-and-Pipeline-Insight-Vaccines-for-Adults-and-the-Elderly---New-blockbuster-opportunities-ahead.html Introduction Vaccines have re-emerged as successful revenue generators for Big Pharma, with...

2008-05-15 12:00:07

The U.S. Centers for Disease Control and Prevention (CDC) has adopted the unanimous recommendation of its Advisory Committee on Immunization Practices (ACIP) for the use of ZOSTAVAX(R) (Zoster Vaccine Live) for the prevention of shingles in adults aged 60 and older. ZOSTAVAX is the only vaccine to prevent shingles, a frequently painful disease marked by a blistering rash that is caused by the reactivation of the chickenpox virus. These final vaccination guidelines were published online today...

2006-10-27 18:00:49

By Daniel Lee, The Indianapolis Star Oct. 27--Many people over 60 soon will have easier and more affordable access to a vaccine that helps prevent the painful and common condition known as shingles. Health insurers are adding the vaccine, Zostavax, to their drug coverage after the immunization advisory committee with the U.S. Centers for Disease Control and Prevention recommended the shot for older patients. Shingles, caused by the reactivation of the chickenpox virus, tends to...

2006-10-26 09:00:57

INDIANAPOLIS, Oct. 26 /PRNewswire/ -- WellPoint, Inc. announced today that effective immediately it will cover the vaccine Zostavax(TM), designed to prevent shingles, a painful condition resulting from the reactivation of the chickenpox virus, typically in older individuals. The vaccine will be covered for individuals 60 years of age and older whose benefit plans provide coverage for vaccines. WellPoint already provides benefits for Zostavax through its Medicare Part D benefit based on...

2006-05-26 13:08:32

By Toni Clarke and Susan Heavey BOSTON/WASHINGTON (Reuters) - U.S. health officials on Friday approved the first vaccine to prevent shingles, a painful disease characterized by a blistering rash that affects nearly 1 million, mostly older adults every year. The vaccine, Zostavax, which is made by Merck & Co. and aims to boost the immune system, was approved for adults age 60 and older. Shingles is caused by a reactivation of the virus that causes chickenpox. Treatments generally...

2006-05-26 06:51:42

In BOSTON story headlined "FDA approves Merck vaccine to prevent shingles," please read in second paragraph ... The vaccine is designed to prevent shingles ... instead of ... The vaccine is designed to treat shingles. A corrected version follows. BOSTON (Reuters) - Merck & Co. said on Friday that the U.S. Food and Drug Administration has approved its vaccine to prevent shingles, a painful disease characterized by a blistering rash. The vaccine, Zostavax, is designed to prevent...


Latest Zostavax Reference Libraries

69_7b87211f9314eacab994d465558a3a1b
2011-01-24 12:56:26

Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...

More Articles (1 articles) »
Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.